Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia

British Journal of Anaesthesia

Volumn 86, Issue 4, 2001, Pages 550-554

  Toner, C C ^a   Connelly, K ^b   Whelpton, R ^b   Bains, S ^b   Michael Titus, A T ^b   McLaughlin, D P ^a   Stamford, J A ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anaesthetics volatile, sevoflurane; Brain, ischaemia

Indexed keywords

ASPARTIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE; EXCITATORY AMINO ACID; GLUCOSE; GLUTAMIC ACID; HALOTHANE; INHALATION ANESTHETIC AGENT; NEUROTRANSMITTER; OXYGEN; SEVOFLURANE; SODIUM CHANNEL BLOCKING AGENT;

AMINO ACID TRANSPORT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG EFFECT; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MALE; MEASUREMENT; NERVE CELL LESION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT; TEMPERATURE;

EID: 0035065469     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/86.4.550     Document Type: Article

References (29)

1. Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia
2. Sevoflurane-a long-awaited volatile anaesthetic
3. Effects of sevoflurane on intracranial pressure, cerebral blood flow and cerebral metabolism-a dose-response study in patients subjected to craniotomy for cerebral tumours
4. Effect of incremental doses of sevoflurane on cerebral pressure autoregulation in humans
5. Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Possible influence on thermoregulation
6. Origins of glutamate release in ischaemia
7. Real time measurement of dopamine release in an in vitro model of neostriatal ischaemia
8. Effects of halothane on ischaemia-induced striatal dopamine release in vitro
9. Haemodynamic and organ blood flow responses to sevoflurane during spontaneous ventilation in the rat: A dose-response study
10. Microbore liquid chromatography analysis of amino acid transmitters
11. Glutamate receptor antagonists in cerebral ischaemia
12. Dopamine has inhibitory and accelerating effects on ischaemia-induced neuronal damage in the rat striatum
13. Involvement of N- and P/Q- but not L- or T-type voltage-gated calcium channels in ischaemia-induced striatal dopamine release in vitro
14. Sodium channel blockade unmasks two temporally distinct mechanisms of striatal dopamine release during hypoxia/hypoglycaemia in vitro
15. Characteristics of the NMDA receptor modulating hypoxia/hypoglycaemia-induced rat striatal dopamine release in vitro
16. Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia
17. The role of glutamate transporters in glutamate homeostasis in the brain
18. 3H]-dopamine from rat striatal slices
19. General anaesthetics as neuroprotective agents
20. 3H]D-2-Amino-5-phosphonopentanoate as a ligand for N-methyl-D-aspartate receptors in the mammalian central nervous system
21. Sevoflurane improves neurological outcome after incomplete cerebral ischaemia in rats
22. The effects of sevoflurane on recovery of brain energy metabolism after cerebral ischemia in the rat: A comparison with isoflurane and halothane
23. Isoflurane and sevoflurane interact with the nicotinic acetylcholine receptor channels in micromolar concentrations
24. B receptors in area CAI of rat hippocampus
25. A receptor kinetics: Evidence for slowed agonist unbinding
26. Increase of glutamate uptake in astrocytes-a possible mechanism of action of volatile anesthetics
27. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST
28. Multiple ionic mechanisms mediate inhibition of rat motoneurones by inhalation anaesthetics